Company Overview

Azenta, Inc. is a life sciences solutions provider focused on enabling biological and pharmaceutical research, development, and clinical workflows. The company operates primarily in the life sciences tools and services industry, supporting customers across biopharmaceutical, academic, clinical, and healthcare markets. Azenta’s core offerings are designed to manage, store, analyze, and protect biological samples and related data throughout the research and development lifecycle.

The company’s primary revenue drivers include automated sample management systems, genomic and multiomic services, cryogenic storage solutions, and cold-chain technologies. Azenta is positioned as an integrated provider combining physical sample infrastructure with laboratory services and informatics, which differentiates it from single-product competitors. The company traces its origins to Brooks Automation, which historically focused on semiconductor automation; following a strategic transformation and divestiture of the semiconductor business, the life sciences segment was rebranded as Azenta, Inc. in 2021 and began operating as a standalone public company.

Business Operations

Azenta generates revenue through multiple operating segments that support sample-centric research and healthcare workflows. Its principal business lines include Sample Management Solutions, Multiomics, and B Medical Systems. Sample Management Solutions provides automated storage systems, consumables, and software for high-density biological sample storage, while also offering outsourced biorepository services. Multiomics delivers genomic, gene expression, and other molecular analysis services that support discovery, translational research, and clinical development.

The company operates both domestically and internationally, with owned laboratories, manufacturing facilities, and service centers. Through its acquisition of B Medical Systems, Azenta expanded into vaccine cold-chain equipment, blood storage, and temperature-controlled transport solutions used by healthcare systems and global health organizations. Azenta controls proprietary automation technologies, cryogenic storage platforms, and laboratory service capabilities, and maintains customer relationships across long-term contracts, project-based services, and equipment sales.

Strategic Position & Investments

Azenta’s strategic direction emphasizes becoming a comprehensive partner for biological sample lifecycle management, from collection and analysis to long-term storage and distribution. Growth initiatives have focused on expanding outsourced services, increasing penetration in clinical and biopharmaceutical markets, and cross-selling genomic services with sample storage solutions. The acquisition of B Medical Systems represents a significant strategic investment, extending Azenta’s reach into healthcare infrastructure and public health supply chains.

The company continues to invest in automation, informatics integration, and scalable laboratory capacity to support emerging modalities such as cell and gene therapies. Azenta’s portfolio reflects exposure to expanding sectors within life sciences, including precision medicine, biobanking, and global vaccine distribution, positioning the company to benefit from long-term growth in research intensity and biologics development.

Geographic Footprint

Azenta is headquartered in North America, with its corporate headquarters in Burlington, Massachusetts. The company maintains a broad international presence across Europe, Asia-Pacific, Latin America, and Africa, supporting both commercial customers and public-sector health initiatives. Its global laboratory and service infrastructure enables regional sample processing, storage, and logistics support.

Through B Medical Systems and its sample management operations, Azenta has operational and commercial reach in more than 100 countries. This geographic diversification allows the company to serve multinational biopharmaceutical clients, academic research networks, and international health organizations, while also reducing reliance on any single regional market.

Leadership & Governance

Azenta is led by an executive management team responsible for overseeing its transition from an automation-focused heritage to a life sciences–centric growth strategy. The company’s leadership emphasizes operational excellence, customer integration, and disciplined capital allocation aligned with long-term value creation. Strategic vision, as described in public filings, centers on building a scalable, global platform for sample-based research and healthcare solutions.

Based on available public disclosures, specific executive role details and titles show variability across reporting periods. Data inconclusive based on available public sources with respect to consistently verified current executive listings.